Actively Recruiting
Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2020-12-17
500
Participants Needed
1
Research Sites
1669 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The long-term outcomes of adult patients with pulmonary Langerhans cell histiocytosis (PLCH), particularly survival, is largely unknown. This is the first prospective study in the field evaluating the long-term outcomes of PLCH patients. This french countrywide registry-based study included a large cohort of PLCH patients followed for a sufficiently long period to address risk factors of long-term outcomes of PLCH patients.
CONDITIONS
Official Title
Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �3E= 18 years
- Diagnosis of PLCH confirmed by biopsy or by typical clinical picture, nodulo-cystic pattern on lung HRCT, and exclusion of other diagnoses
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
French national reference centre for Histiocytoses
Paris, France, 75010
Actively Recruiting
Research Team
A
Abdellatif TAZI, MD PhD
CONTACT
M
matthieu resche-rigon, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here